These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


282 related items for PubMed ID: 16222356

  • 1. Mesalazine-associated acute tubulointerstitial nephritis in a patient with spondylarthropathy.
    Sari I, Birlik M, Cavdar C, Sarioglu S, Akpinar H, Onen F, Akkoc N.
    N Z Med J; 2005 Sep 16; 118(1222):U1662. PubMed ID: 16222356
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute interstitial nephritis due to mesalazine.
    Tadic M, Grgurevic I, Scukanec-Spoljar M, Bozic B, Marusic S, Horvatic I, Galesic K.
    Nephrology (Carlton); 2005 Apr 16; 10(2):103-5. PubMed ID: 15877665
    [Abstract] [Full Text] [Related]

  • 5. Mesalazine-induced interstitial nephritis.
    Skalova S, Dedek P, Pozler O, Podhola M.
    Ren Fail; 2009 Apr 16; 31(2):159-61. PubMed ID: 19212915
    [Abstract] [Full Text] [Related]

  • 6. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.
    Calviño J, Romero R, Pintos E, Losada E, Novoa D, Güimil D, Mardaras J, Sanchez-Guisande D.
    Clin Nephrol; 1998 Apr 16; 49(4):265-7. PubMed ID: 9582560
    [Abstract] [Full Text] [Related]

  • 7. [Mesalazine-induced nephropathy].
    Zaragoza Marcet A, Ivorra Cortés J.
    Rev Esp Enferm Dig; 2001 Aug 16; 93(8):548. PubMed ID: 11692787
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 5-ASA therapy and renal function in inflammatory bowel disease.
    Siveke JT, Egert J, Sitter T, Schiemann U, Walcher P, Török HP, Glas J, Folwaczny C.
    Am J Gastroenterol; 2005 Feb 16; 100(2):501. PubMed ID: 15667517
    [No Abstract] [Full Text] [Related]

  • 10. [Interstitial nephritis induced by mesalazine].
    Ohya M, Otani H, Kimura K, Kodama N, Minami Y, Liang XM, Maeshima E, Yamada Y, Mune M, Yukawa S.
    Nihon Jinzo Gakkai Shi; 2002 May 16; 44(4):414-9. PubMed ID: 12073628
    [Abstract] [Full Text] [Related]

  • 11. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
    Corrigan G, Stevens PE.
    Aliment Pharmacol Ther; 2000 Jan 16; 14(1):1-6. PubMed ID: 10632639
    [Abstract] [Full Text] [Related]

  • 12. Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
    Frandsen NE, Saugmann S, Marcussen N.
    Nephron; 2002 Sep 16; 92(1):200-2. PubMed ID: 12187103
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relapsing tubulointerstitial nephritis in an adolescent with inflammatory bowel disease without aminosalicylate exposure.
    Shahrani Muhammad HS, Peters C, Casserly LF, Dorman AM, Watts M.
    Clin Nephrol; 2010 Mar 16; 73(3):250-2. PubMed ID: 20178728
    [Abstract] [Full Text] [Related]

  • 17. [Tubulointerstitial nephritis associated with drug reactions].
    Kitazawa K.
    Nihon Rinsho; 2007 Oct 28; 65 Suppl 8():554-8. PubMed ID: 18074601
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Association of Mesalamine With Kidney Disease.
    Adiga A, Goldfarb DS.
    Adv Chronic Kidney Dis; 2020 Jan 28; 27(1):72-76. PubMed ID: 32147005
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.